{"brief_title": "Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer", "brief_summary": "This study will test whether the G17DT Immunogen, when administered in combination with chemotherapy, is an effective and safe treatment for gastric cancer.", "condition": "Esophageal Neoplasms", "intervention_type": "Biological", "intervention_name": "Treatment group", "arm_group_label": "Treatment Group", "criteria": "Inclusion criteria: - Clinical diagnosis with gastric or gastroesophageal cancer - Karnofsky performance status score of at least 70 - Life expectancy of at least 3 months Exclusion criteria: - Prior treatment with chemotherapy or anticancer immunotherapy - Bone marrow transplant within past year - Chronic use of corticosteroids, except for inhaled corticosteroids used for asthma or chronic obstructive pulmonary disease - Central nervous system metastases - Immunodeficiency - Hypercalcemia", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00042510.xml"}